MONTE ROSA THERAPEUTICS, INC.
MONTE ROSA THERAPEUTICS, INC. is a registered legal entity registered in United States under 7715213, and its current status with Delaware Division of Corporations is active. The company was incorporated on 11 September 2020 and lists its registered address as United States. 5 shareholders are on record for MONTE ROSA THERAPEUTICS, INC., and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn. This profile is sourced directly from Delaware Division of Corporations and was last updated on 4 October 2026.
- Company fundamentals
- Corporate linkage & group structures
- Digitized company financials
- Firmographics — websites, social profiles, revenue and employee estimates
Shareholders
5
Five shareholders are currently on record for MONTE ROSA THERAPEUTICS, INC., reflecting the stock ledger maintained under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing.
The largest of these is Vanguard Group Inc, holding 6.1% — the largest recorded stake — followed by iShares Trust-iShares Russell 2000 ETF at 2.2%; the remaining 3 shareholders shown hold smaller stakes.
The register reports 6 shareholders in total, though only the top 5 by holding are shown in this view.
Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
| Shareholder | Type | Holding | Source Document |
|---|---|---|---|
| Vanguard Group Inc | 6.1% | Delaware Division of Corporations | |
| iShares Trust-iShares Russell 2000 ETF | 2.2% | Delaware Division of Corporations | |
| T. Rowe Price Health Sciences Fund, Inc. | 1.9% | Delaware Division of Corporations | |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 0.9% | Delaware Division of Corporations | |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 0.9% | Delaware Division of Corporations |
Officers
5
The President, Ceo & Director of MONTE ROSA THERAPEUTICS, INC. currently on record is Markus Warmuth M.d.; five officers are currently on record for MONTE ROSA THERAPEUTICS, INC., filed with Delaware Division of Corporations.
The register reports 9 officers in total, including past appointments, though only the 5 most relevant records are shown here.
Management authority at MONTE ROSA THERAPEUTICS, INC. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.
Group Structure
MONTE ROSA THERAPEUTICS, INC. has no recorded parent company — it sits at the top of its own group structure, with 2 subsidiaries recorded beneath it across 2 jurisdictions. Each of these downward relationships is derived rather than filed: resolved by matching entities across the registry network, not stated directly in a single document.
Those 2 subsidiaries span United States, Switzerland jurisdictions, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear.
MONTE ROSA THERAPEUTICS, INC.
United States
Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.
Frequently Asked Questions
Who owns MONTE ROSA THERAPEUTICS, INC.?
Five shareholders are currently on record for MONTE ROSA THERAPEUTICS, INC., reflecting the stock ledger maintained under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing. The largest of these is Vanguard Group Inc, holding 6.1% — the largest recorded stake — followed by iShares Trust-iShares Russell 2000 ETF at 2.2%; the remaining 3 shareholders shown hold smaller stakes. Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
Who is MONTE ROSA THERAPEUTICS, INC.'s UBO (Ultimate Beneficial Owner)?
Every shareholder recorded for MONTE ROSA THERAPEUTICS, INC. is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.
How many shareholders does MONTE ROSA THERAPEUTICS, INC. have on record?
5 shareholders are shown on record for MONTE ROSA THERAPEUTICS, INC.. The register reports 6 in total; only the top 5 by holding are shown here.
What is MONTE ROSA THERAPEUTICS, INC.'s company registration number?
MONTE ROSA THERAPEUTICS, INC.'s registration number is 7715213, filed with Delaware Division of Corporations in United States. Its current status on the register is active.
Is MONTE ROSA THERAPEUTICS, INC. still an active company?
MONTE ROSA THERAPEUTICS, INC.'s status on Delaware Division of Corporations is listed as active.
When was MONTE ROSA THERAPEUTICS, INC. incorporated?
MONTE ROSA THERAPEUTICS, INC. was incorporated on 11 September 2020, according to Delaware Division of Corporations.
What is MONTE ROSA THERAPEUTICS, INC.'s registered address?
The registered address on file for MONTE ROSA THERAPEUTICS, INC. is United States.
Who are the officers/directors of MONTE ROSA THERAPEUTICS, INC.?
The President, Ceo & Director of MONTE ROSA THERAPEUTICS, INC. currently on record is Markus Warmuth M.d.; five officers are currently on record for MONTE ROSA THERAPEUTICS, INC., filed with Delaware Division of Corporations. Management authority at MONTE ROSA THERAPEUTICS, INC. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
Does MONTE ROSA THERAPEUTICS, INC. have a parent company or subsidiaries?
MONTE ROSA THERAPEUTICS, INC. has no recorded parent company — it sits at the top of its own group structure, with 2 subsidiaries recorded beneath it across 2 jurisdictions. Those 2 subsidiaries span United States, Switzerland jurisdictions, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear.
Can Zavia monitor changes to MONTE ROSA THERAPEUTICS, INC.'s ownership over time?
This profile reflects a point-in-time snapshot from Delaware Division of Corporations. Zavia's monitoring API can track changes to MONTE ROSA THERAPEUTICS, INC.'s registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.
Can I access MONTE ROSA THERAPEUTICS, INC.'s data through an API?
Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including United States, so records like MONTE ROSA THERAPEUTICS, INC.'s registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.
Where does this company information come from, and how current is it?
This record is sourced directly from Delaware Division of Corporations and was last synced on 4 October 2026.